LMVOX | Focused Small Cap Value Fund Class F3 | Lord Abbett

Tracked Funds

You have 0 funds on your mutual fund watch list.

Begin by selecting funds to create a personalized watch list.

(as of 12/05/2015)

Pending Orders

You have 0 items in your cart.

Subscribe and order forms, fact sheets, presentations, and other documents that can help advisers grow their business.

 

Focused Small Cap Value Fund

Track this Fund
Add to Hypo Tool

Summary

Summary

What is the Focused Small Cap Value Fund?

The Fund seeks to deliver long-term growth of capital by investing primarily in stocks of small U.S. companies.

Fund Basicsas of 08/31/2022

Total Net Assets
$140.47 M
Inception Date
06/28/2019
Dividend Frequency
Annually
Fund Expense Ratio
0.95%
Number of Holdings
42

Fund Expense Ratio :

0.95%

YTD 1-YR 3-YR 5-YR 10-YR Since Inception
w/o sales charge -24.28% -19.42% 4.91% 3.28% 9.03% -
Lipper Category Avg. Small-Cap Core Funds -22.28% -17.54% 4.58% 3.47% 8.13% -
Russell 2000® Value Index -21.12% -17.69% 4.72% 2.87% 7.94% -

Fund Expense Ratio :

0.95%

Fund Expense Ratio :

0.95%

YTD 1-YR 3-YR 5-YR 10-YR Since Inception
w/o sales charge -24.28% -19.42% 4.91% 3.28% 9.03% -
Lipper Category Avg. Small-Cap Core Funds -22.28% -17.54% 4.58% 3.47% 8.13% -
Russell 2000® Value Index -21.12% -17.69% 4.72% 2.87% 7.94% -

Fund Expense Ratio :

0.95%

INVESTMENT TEAM

John C. Hardy
John C. Hardy

Portfolio Manager

19 Years of Industry Experience

Supported By 35 Investment Professionals with 19 Years Avg. Industry Experience

Your Representative

To contact your representative, enter your zip code and select your channel below.

Performance

Performance

Fund Expense Ratio :

0.95%

YTD 1-YR 3-YR 5-YR 10-YR Since Inception
w/o sales charge -24.28% -19.42% 4.91% 3.28% 9.03% -
Lipper Category Avg. Small-Cap Core Funds -22.28% -17.54% 4.58% 3.47% 8.13% -
Russell 2000® Value Index -21.12% -17.69% 4.72% 2.87% 7.94% -

Fund Expense Ratio :

0.95%

Fund Expense Ratio :

0.95%

YTD 1-YR 3-YR 5-YR 10-YR Since Inception
w/o sales charge -24.28% -19.42% 4.91% 3.28% 9.03% -
Lipper Category Avg. Small-Cap Core Funds -22.28% -17.54% 4.58% 3.47% 8.13% -
Russell 2000® Value Index -21.12% -17.69% 4.72% 2.87% 7.94% -

Fund Expense Ratio :

0.95%

Year Fund Returns Russell 2000® Value Index
2021 27.55% 28.27%
2020 8.62% 4.63%
2019 20.81% 22.39%
2018 -9.24% -12.86%
2017 7.60% 7.84%
2016 30.79% 31.74%
2015 2.14% -7.47%
2014 -0.14% 4.22%
2013 38.27% 34.52%
2012 18.81% 18.05%
2011 -9.62% -
2010 27.98% -
2009 33.76% -
Year Q1 Q2 Q3 Q4 Yearly Returns
2022 -5.03% -16.47% -4.54% - -19.70%
2021 19.34% 3.80% -3.24% 6.42% 27.55%
2020 -42.22% 34.40% 0.83% 38.71% 8.62%
2019 11.58% 1.73% -3.29% 10.05% 20.81%
2018 0.44% 8.58% 1.80% -18.25% -9.24%
2017 -0.74% 1.69% 4.34% 2.15% 7.60%
2016 1.05% 7.61% 6.89% 12.52% 30.79%
2015 3.84% -0.75% -4.25% 3.51% 2.14%
2014 0.77% 2.75% -7.55% 4.31% -0.14%
2013 10.59% 3.36% 7.42% 12.62% 38.27%
2012 13.43% -5.36% 6.44% 3.97% 18.81%
2011 5.38% -2.38% -24.86% 16.92% -9.62%
2010 9.04% -6.13% 7.19% 16.65% 27.98%
2009 - 29.11% 14.63% 0.90% 33.76%

NAV HISTORICAL PRICES

Date Net Asset Value

Portfolio

Portfolio

Portfolio Positioningas of 6/30/2022

  • The Fund employs a fundamental, bottom-up individual stock selection strategy that focuses on quality companies with compelling valuation over a long term horizon.
  • We initiated a position in shares of Belden Inc., a property and casualty insurance provider. We believe they are attractively valued following years of low-return acquisitions. Under new management, the company has cleaned up its balance sheet by selling select low-return businesses and now produces high returns on tangible capital.
  • We also initiated a position in shares of Physicians Realty Trust, a real estate investment trust, which engages in the acquisition, development, owning, and managing of healthcare properties. We believe they are attractively valued relative to their peers. We believe medical office buildings are an attractive property type with solid growth prospects driven by stable tenant demand, a long-term demographic tailwind, and an increase in medical procedures being performed in non-hospital settings.
  • We sold the Fund’s position in Metropolitan Bank Holding Corp., a bank holding company. Our thesis regarding the strength of their deposit base has become increasingly challenged.
  • We also sold the Fund’s position in Silicon Motion Technology, which engages in the development, manufacturing, and supply of semiconductor products for the electronics market. Following the announcement that MaxLinear would acquire Silicon Motion Technology, we exited our position.

PORTFOLIO DETAILS as of 08/31/2022

Total Net Assets
$140.47 M
Number of Holdings
42
Weighted Average Market Cap.
3.4 B
P/B Ratio
2.0x
P/E Ratio
12.5x

Fees & Expenses

Fees & Expenses

EXPENSE RATIOas of 09/30/2022

0.95%

Fund Documents

Fund Documents

Download fund documents & literature, create email subscriptions, and place direct mail order

0Documents selected
Order
n/a
Portfolio Holdings 1Q
Publish Date:11/03/2015
n/a
Portfolio Holdings 3Q
Publish Date:11/03/2015
Summary Prospectus
Publish Date:11/03/2015
n/a
Statutory Prospectus
Publish Date:11/03/2015
SAI
Publish Date:11/03/2015
Annual Report
Publish Date:11/03/2015
Semi-Annual Report
Publish Date:11/03/2015
Fact Sheet
Publish Date:11/03/2015
Commentary
Publish Date:11/03/2015

To order literature visit full website

You may add to your cart by selecting quantities in each row below.

No rows selected. Please Go back and select at least one fund document

 
Quantity
Quantity
Remove
Remove

Select funds to run a Morningstar Hypothetical Report.

    Please confirm your literature shipping address

    Please review the address information below and make any necessary changes.

    All literature orders will be shipped to the address that you enter below. This information can be edited at any time.

    Current Literature Shipping Address

    * Required field